Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: A double-blind, randomized, placebo-controlled study

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2760-2763

  Ueland, T ^a   Bollerslev, J ^b   Flyvbjerg, A ^b   Hansen, T B ^c   Vahl, N ^b   Mosekilde, L ^d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DESMOPRESSIN; HUMAN GROWTH HORMONE; HYDROCHLORIC ACID; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PLACEBO; PROTEIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; THYROXINE;

ADULT; ARTICLE; BIOMECHANICS; BONE BIOPSY; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; EXTRACTION; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; ILIAC CREST; JOINT FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; TRABECULAR BONE;

EID: 0036075085     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8549     Document Type: Article

References (30)

1. Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover
2. Reduced bone mineral density in patients with adult onset growth hormone deficiency
3. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency
4. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency
5. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism
6. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis and bone metabolism in adults with acquired GH deficiency: A double blind, randomized, placebo-controlled study
7. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency
8. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deflcient adults
9. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme
10. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy
11. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia
12. Insulin-like growth factors (IGF)-I and -II and IGF binding protein-1, -2, and -3 in patients with acromegaly before and after adenomectomy
13. Increased cortical bone content of insulin-like growth factors in acromegalic patients
14. Clinical review 114: Hot topic. The role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases
15. Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: A 1-year, double-blind, randomized, placebo-controlled study
16. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid- ethanol treatment and C18 Sep-Pak separation
17. Extraction of osteocalcin from fossil bones and teeth
18. Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess: Possible role in bone homeostasis
19. Activated human T cells directly induce osteoclastogenesis from human monocytes: Possible role of T cells in bone destruction in rheumatoid arthritis patients
20. Rapid colorimetric determination of calcium in biologic fluids with methylthymol blue
21. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats
22. Normal growth and development in the absence of hepatic insulin-like growth factor I
23. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
24. Identification and characterization of the insulin-like growth factor I receptor in mature rabbit osteoclasts
25. Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: An in vitro study
26. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-α production
27. Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I
28. Growth hormone increases interleukin-6 produced by human osteoblast-like cells
29. Immunological characterization of circulating osteoprotegerin/osteodastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis
30. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells